N/A
Completed N=20
Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics
Specific Phobia
Source: ClinicalTrials.gov NCT01450306 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Apr 2016
Primary outcomePrimary: Snake Questionnaire (SNAQ) — 9.6; 9.7 units on a scale
Summary
The aim of the present study is to determine whether people receiving d-cycloserine and exposure therapy show different brain reactions to symptom provocation compared to people receiving placebo and exposure therapy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Snake Questionnaire (SNAQ) |
9.6; 9.7 | — |
| SECONDARY Clinician's Global Impression (CGI)-Severity |
3; 2.7 | — |
| SECONDARY Clinician's Global Impression (CGI)-Improvement |
8; 9 | — |
Eligibility Criteria
Inclusion Criteria
- Primary diagnosis of specific phobia (snakes)
Exclusion Criteria
- History of psychosis, obsessive-compulsive disorder, or mania
- Recent substance abuse or suicidality
- Previous receipt of study treatments
Data sourced from ClinicalTrials.gov (NCT01450306). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.